Is CJC-1295 (with DAC) FDA approved?
No. This profile records CJC-1295 (with DAC) as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE GH SUSTAINER
CJC-1295 DAC, GRF (1-29) analog with DAC, CJC-1295 w/ DAC
CJC-1295 with DAC (Drug Affinity Complex) binds to albumin in your blood, extending its half-life to about a week. That means just 1-2 injections weekly produce sustained growth hormone elevation. That's convenient, but the steady GH bleed is less physiologic than the pulsatile pattern your body produces naturally.
Not FDA approved · research use only
Reviewed by our clinical team
Sources pending
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records CJC-1295 (with DAC) as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 1-2 mg per week (typically split into 2 doses).
Schedule: twice_weekly. Cycle: 8 weeks on, 8 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
No linked research sources are currently available on this guide.
Treat the profile as provisional until supporting sources are published.
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.